Evaluation of ocean biomass products that activate cell-medicated immunity in mice cutaneously infected with herpes simplex virus type 1
- 1. Department of Biochemistry, Graduate School of Clinical Pharmacy, Kyushu University of Health and Welfare, Nobeoka 882-8508, Japan.
- 2. Department of Pharmaceutical Health Sciences, Graduate School of Clinical Pharmacy, Kyushu University of Health and Welfare, Nobeoka 882-8508, Japan.
- 3. Department of Microbiology, Graduate School of Clinical Pharmacy, Kyushu University of Health and Welfare, Nobeoka 882-8508, Japan.
Description
We screened and evaluated the activation of cell-medicated immunity by ocean biomass products using a cutaneous herpes simplex virus type 1 (HSV-1) infection model. In this model, a delayed-type hypersensitivity (DTH) associated with cell-mediated immunity is an important immune defense systems. An aqueous fraction of ovary of Seriola quinqueradiata (A-SQ) or a lipophilic fraction of head and internal organs of Hymenocephalus lethonemus (L-HL) was administered orally to mice infected with HSV-1 three times daily during 8 days (days 0 to 7) after infection. They delayed the progress of herpetic skin lesions without toxicity and significantly increased the DTH reaction to inactivated HSV-1 antigen on the footpads of infected mice. Further, A-SQ and L-HL increased the production of interferon-γ from splenocytes of HSV-1-infected mice by the inactivated-HSV-1. Thus, the efficacies of A-SQ and L-HL against HSV-1 infection may be due to the augmentation of cell-mediated immunity through DTH reaction.
Files
WJBPHS-2020-0017.pdf
Files
(802.0 kB)
Name | Size | Download all |
---|---|---|
md5:f18797dc4968e5186b001645968338cd
|
802.0 kB | Preview Download |